Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.08 USD | -2.40% | +1.45% | -10.85% |
05-10 | Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering | MT |
05-08 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.85% | 1.4B | |
+35.01% | 709B | |
+31.16% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.68% | 239B | |
+9.40% | 211B | |
-4.13% | 203B | |
+10.77% | 171B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Barclays Adjusts Pacira BioSciences' Price Target to $57 From $60, Maintains Overweight Rating